Xin Zhi

ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN

Lloyd Paul Aiello, Louis Vignati, Matthew J. Sheetz et al. · Retina · 2011 · 96 citations

Medicine, Ophthalmology, Pharmacology +17

Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer

Mario Campone, Michelino De Laurentiis, Komal Jhaveri et al. · New England Journal of Medicine · 2025 · 94 citations

Medicine, Oncology, Pharmacology +17

Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-standing Diabetic Macular Edema

Matthew D. Davis, Matthew J. Sheetz, Lloyd Paul Aiello et al. · Investigative Ophthalmology & Visual Science · 2009 · 87 citations · Full text

Medicine, Ophthalmology, Pharmacology +17

Diabetic macular oedema and visual loss: relationship to location, severity and duration

Thomas W. Gardner, Michael Larsen, Aniz Girach et al. · Acta Ophthalmologica · 2009 · 44 citations · Full text

Medicine, Ophthalmology, Optometry +17

A multicenter, randomized, blinded, phase III study of pasireotide LAR versus octreotide LAR in patients with metastatic neuroendocrine tumors (NET) with disease-related symptoms inadequately controlled by somatostatin analogs.

Edward M. Wolin, Barbara Jarząb, Barbro Eriksson et al. · Journal of Clinical Oncology · 2013 · 25 citations

Medicine, Oncology, Pharmacology +13